DTNBP1
DTNBP1 (dystrobrevin binding protein 1), also known as dysbindin, BLOC1S8, HPS7, DBND and My031, is a component of the BLOC-1 complex. It supports the biogenesis of lysosome-related organelles and vesicle trafficking in neurons. Browse Assay Genie's current range of DTNBP1 research reagents below, or read on for the biology behind the target.
DTNBP1 is a component of the BLOC-1 complex (biogenesis of lysosomal organelles complex 1), which is required for normal biogenesis of lysosome-related organelles such as platelet dense granules and melanosomes. Together with the AP-3 complex, BLOC-1 targets membrane protein cargos into vesicles assembled at cell bodies for delivery into neurites and nerve terminals. BLOC-1 is also proposed, in association with SNARE proteins, to be involved in neurite extension. DTNBP1 associates with the BLOC-2 complex to facilitate transport of TYRP1 independently of AP-3 function.
In neurons, dysbindin plays a role in synaptic vesicle trafficking and neurotransmitter release, and in regulating the cell surface exposure of DRD2. It may contribute to actin cytoskeleton reorganisation and neurite outgrowth, and may modulate MAPK8 phosphorylation. It appears to promote neuronal transmission and viability by regulating expression of SNAP25 and SYN1, modulating PI3-kinase-Akt signalling and influencing glutamatergic release. It regulates SYN1 expression by binding to its promoter, and modulates prefrontal cortical activity through the dopamine/D2 pathway. Reported locations include cytoplasm, endosome, melanosome and synaptic vesicle membranes, the postsynaptic density, endoplasmic reticulum and nucleus.
The DTNBP1 gene belongs to the dysbindin family and sits in the HGNC group of BLOC-1 subunits. The name derives from the mouse protein, which binds alpha- and beta-dystrobrevins, components of the dystrophin-associated protein complex. Mutations in the gene are associated with Hermansky-Pudlak syndrome type 7, and the gene may also be associated with schizophrenia. Multiple transcript variants encoding distinct isoforms have been identified. Mouse and rat orthologs are both named Dtnbp1.
DTNBP1 is a BLOC-1 subunit required for biogenesis of melanosomes and platelet dense granules, making it central to studies of these organelles.
Dysbindin contributes to synaptic vesicle trafficking and neurotransmitter release, including glutamatergic release and regulation of SNAP25 and SYN1 expression.
DTNBP1 regulates cell surface exposure of DRD2 and modulates prefrontal cortical activity via the dopamine/D2 pathway.
Mutations in DTNBP1 are associated with Hermansky-Pudlak syndrome type 7, and the gene may also be associated with schizophrenia.
DTNBP1 is a subunit of the BLOC-1 complex, needed for biogenesis of lysosome-related organelles such as melanosomes and platelet dense granules. With AP-3, BLOC-1 targets membrane cargos to neurites and nerve terminals. Dysbindin also acts in synaptic vesicle trafficking and neurotransmitter release.
DTNBP1 stands for dystrobrevin binding protein 1. Its protein product is called dysbindin, and aliases include My031, HPS7, DBND and BLOC1S8. Multiple transcript variants encoding distinct isoforms have been identified, so the literature may describe more than one dysbindin form.
Mouse and rat both carry a Dtnbp1 ortholog, and the mouse protein is a BLOC-1 component that binds alpha- and beta-dystrobrevins. In humans, mutations are associated with Hermansky-Pudlak syndrome type 7, and the gene may also be associated with schizophrenia. Check the datasheet of any product for its validated reactivity.
Other BLOC-1 partners, synaptic proteins and dopamine signalling targets connected to dysbindin biology.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q96EV8; product specifications from Assay Genie datasheets.